J&J Puts A Cork In Eprex Problem: Teflon-Coated Stopper May Solve PRCA
Executive Summary
Johnson & Johnson believes that the incidence of pure red cell aplasia seen with the overseas epoetin brand Eprex was most likely caused by leaching from rubber stoppers used in vials of the product
You may also be interested in...
Amgen Shortens Epogen, Procrit Shelf-lives Following Recall
Firm is working with vial manufacturers to determine the cause of the delamination.
J&J Describes Eprex Safety Findings In Petition Against Follow-On Biologics
Johnson & Johnson believes that safety issues triggered by a change in stabilizers used in production of the erythropoietin Eprex support the biotechnology industry's position that "follow-on" biologics need separate clinical trials
J&J Describes Eprex Safety Findings In Petition Against Follow-On Biologics
Johnson & Johnson believes that safety issues triggered by a change in stabilizers used in production of the erythropoietin Eprex support the biotechnology industry's position that "follow-on" biologics need separate clinical trials